Literature DB >> 23897068

Recent advances in the understanding of the pathophysiology of preeclampsia.

Junie P Warrington1, Eric M George, Ana C Palei, Frank T Spradley, Joey P Granger.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23897068      PMCID： PMC3856636          DOI： 10.1161/HYPERTENSIONAHA.113.00588

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  86 in total

1.  Effects of circulating and local uteroplacental angiotensin II in rat pregnancy.

Authors:  Lydia Hering; Florian Herse; Nele Geusens; Stefan Verlohren; Katrin Wenzel; Anne C Staff; K Bridget Brosnihan; Berthold Huppertz; Friedrich C Luft; Dominik N Muller; Robert Pijnenborg; Judith E Cartwright; Ralf Dechend
Journal:  Hypertension       Date:  2010-06-07       Impact factor: 10.190

2.  Upregulation of urotensin II receptor in preeclampsia causes in vitro placental release of soluble vascular endothelial growth factor receptor 1 in hypoxia.

Authors:  Phillip S Gould; Mei Gu; Jianqin Liao; Shakil Ahmad; Melissa J Cudmore; Asif Ahmed; Manu Vatish
Journal:  Hypertension       Date:  2010-05-17       Impact factor: 10.190

3.  PPAR{gamma} activation prevents hypertensive remodeling of cerebral arteries and improves vascular function in female rats.

Authors:  Marilyn J Cipolla; Nicole Bishop; R Saman Vinke; Julie A Godfrey
Journal:  Stroke       Date:  2010-04-15       Impact factor: 7.914

4.  Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension.

Authors:  Jeffrey S Gilbert; Joseph Verzwyvelt; Drew Colson; Marietta Arany; S Ananth Karumanchi; Joey P Granger
Journal:  Hypertension       Date:  2009-12-21       Impact factor: 10.190

5.  Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats.

Authors:  Sydney R Murphy; B Babbette D LaMarca; Kathy Cockrell; Joey P Granger
Journal:  Hypertension       Date:  2009-12-21       Impact factor: 10.190

6.  Tobacco use during pregnancy and preeclampsia risk: effects of cigarette smoking and snuff.

Authors:  Anna-Karin Wikström; Olof Stephansson; Sven Cnattingius
Journal:  Hypertension       Date:  2010-03-15       Impact factor: 10.190

7.  Inhibition of trophoblast-induced spiral artery remodeling reduces placental perfusion in rat pregnancy.

Authors:  Stefan Verlohren; Nele Geusens; Jude Morton; Iris Verhaegen; Lydia Hering; Florian Herse; Joachim W Dudenhausen; Dominik N Muller; Friedrich C Luft; Judith E Cartwright; Sandra T Davidge; Robert Pijnenborg; Ralf Dechend
Journal:  Hypertension       Date:  2010-07-06       Impact factor: 10.190

Review 8.  Unveiling the vasodilatory actions and mechanisms of relaxin.

Authors:  Kirk P Conrad
Journal:  Hypertension       Date:  2010-05-24       Impact factor: 10.190

9.  Activation of proteinase-activated receptor 2 stimulates soluble vascular endothelial growth factor receptor 1 release via epidermal growth factor receptor transactivation in endothelial cells.

Authors:  Bahjat Al-Ani; Peter W Hewett; Melissa J Cudmore; Takeshi Fujisawa; Mahmoud Saifeddine; Hannah Williams; Wenda Ramma; Samir Sissaoui; Padma-Sheela Jayaraman; Motoi Ohba; Shakil Ahmad; Morley D Hollenberg; Asif Ahmed
Journal:  Hypertension       Date:  2010-02-01       Impact factor: 10.190

10.  Increased sensitivity to angiotensin II is present postpartum in women with a history of hypertensive pregnancy.

Authors:  Aditi R Saxena; S Ananth Karumanchi; Nancy J Brown; Caroline M Royle; Thomas F McElrath; Ellen W Seely
Journal:  Hypertension       Date:  2010-03-22       Impact factor: 10.190
View more
  34 in total

1.  Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.

Authors:  M R Luizon; A C T Palei; V A Belo; L M Amaral; R Lacchini; G Duarte; R C Cavalli; V C Sandrim; J E Tanus-Santos
Journal:  Pharmacogenomics J       Date:  2016-05-10       Impact factor: 3.550

2.  Vitamin D status and hypertensive disorders in pregnancy.

Authors:  Heather H Burris; Sheryl L Rifas-Shiman; Susanna Y Huh; Ken Kleinman; Augusto A Litonjua; Emily Oken; Janet W Rich-Edwards; Carlos A Camargo; Matthew W Gillman
Journal:  Ann Epidemiol       Date:  2014-02-15       Impact factor: 3.797

Review 3.  Residual vascular dysfunction in women with a history of preeclampsia.

Authors:  Anna E Stanhewicz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-08-22       Impact factor: 3.619

Review 4.  Metabolic abnormalities and obesity's impact on the risk for developing preeclampsia.

Authors:  Frank T Spradley
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-11-30       Impact factor: 3.619

5.  The glucagon-like peptide 1 receptor agonist liraglutide attenuates placental ischemia-induced hypertension.

Authors:  Subhi Talal Younes; Kenji J Maeda; Jennifer Sasser; Michael J Ryan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-11-15       Impact factor: 4.733

6.  Maternal lipids, BMI and IL-17/IL-35 imbalance in concurrent gestational diabetes mellitus and preeclampsia.

Authors:  Weiping Cao; Xinzhi Wang; Tingmei Chen; Wenlin Xu; Fan Feng; Songlan Zhao; Zuxian Wang; Yu Hu; Bing Xie
Journal:  Exp Ther Med       Date:  2018-05-10       Impact factor: 2.447

7.  Up-regulation of CD81 inhibits cytotrophoblast invasion and mediates maternal endothelial cell dysfunction in preeclampsia.

Authors:  Li Shen; Zhenyu Diao; Hai-Xiang Sun; Gui-Jun Yan; Zhiqun Wang; Ruo-Tian Li; Yimin Dai; Jingmei Wang; Jie Li; Hailing Ding; Guangfeng Zhao; Mingming Zheng; Pingping Xue; Mo Liu; Yan Zhou; Yali Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-06       Impact factor: 11.205

8.  Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Authors:  John V Ilekis; Ekaterini Tsilou; Susan Fisher; Vikki M Abrahams; Michael J Soares; James C Cross; Stacy Zamudio; Nicholas P Illsley; Leslie Myatt; Christine Colvis; Maged M Costantine; David M Haas; Yoel Sadovsky; Carl Weiner; Erik Rytting; Gene Bidwell
Journal:  Am J Obstet Gynecol       Date:  2016-03-10       Impact factor: 8.661

Review 9.  Increased risk for the development of preeclampsia in obese pregnancies: weighing in on the mechanisms.

Authors:  Frank T Spradley; Ana C Palei; Joey P Granger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-10-07       Impact factor: 3.619

Review 10.  The Endothelin System: A Critical Player in the Pathophysiology of Preeclampsia.

Authors:  Joey P Granger; Frank T Spradley; Bhavisha A Bakrania
Journal:  Curr Hypertens Rep       Date:  2018-04-10       Impact factor: 5.369
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.